![](/img/cover-not-exists.png)
Therapeutic Potential of Afatinib for Cancers with ERBB2 ( HER2 ) Transmembrane Domain Mutations G660D and V659E
Yamamoto, Hiromasa, Toyooka, Shinichi, Ninomiya, Takashi, Matsumoto, Shigemi, Kanai, Masashi, Tomida, Shuta, Kiura, Katsuyuki, Muto, Manabu, Suzawa, Ken, Desmeules, Patrice, Kris, Mark G., Li, Bob T.,Language:
english
Journal:
The Oncologist
DOI:
10.1634/theoncologist.2017-0345
Date:
November, 2017
File:
PDF, 396 KB
english, 2017